Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort

Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort

Abstract Aims Sacubitril/valsartan is safe when initiated during hospitalization in a clinical trial setting. Its safety in real‐life population is not stablished. We compared the initiation of sacubitril/valsartan during hospitalization in a non‐selected population, in the PIONEER‐HF trial, and in...

Full description

Bibliographic Details
Main Authors: Juan Carlos López‐Azor, Lourdes Vicent, María Jesús Valero‐Masa, Alberto Esteban‐Fernández, Manuel Gómez‐Bueno, Ángel Pérez, Pablo Díez‐Villanueva, Javier De‐Juan, Ángel Manuel‐Iniesta, Ramón Bover, Susana delPrado, Manuel Martínez‐Sellés
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:ESC Heart Failure
Subjects:
Heart failure
Sacubitril/valsartan
Reduced ejection fraction
Hospitalization
Online Access:https://doi.org/10.1002/ehf2.12527

Internet

https://doi.org/10.1002/ehf2.12527

Similar Items